Bio-Techne (TECH) Competitors $51.54 +0.14 (+0.27%) Closing price 06/11/2025 04:00 PM EasternExtended Trading$51.54 0.00 (0.00%) As of 08:54 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock TECH vs. MTD, WAT, ILMN, CRL, BIO, BRKR, PACB, HBIO, TMO, and AShould you be buying Bio-Techne stock or one of its competitors? The main competitors of Bio-Techne include Mettler-Toledo International (MTD), Waters (WAT), Illumina (ILMN), Charles River Laboratories International (CRL), Bio-Rad Laboratories (BIO), Bruker (BRKR), Pacific Biosciences of California (PACB), Harvard Bioscience (HBIO), Thermo Fisher Scientific (TMO), and Agilent Technologies (A). These companies are all part of the "life sciences tools & services" industry. Bio-Techne vs. Its Competitors Mettler-Toledo International Waters Illumina Charles River Laboratories International Bio-Rad Laboratories Bruker Pacific Biosciences of California Harvard Bioscience Thermo Fisher Scientific Agilent Technologies Bio-Techne (NASDAQ:TECH) and Mettler-Toledo International (NYSE:MTD) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, earnings, analyst recommendations, community ranking, valuation, media sentiment, profitability and risk. Do insiders & institutionals believe in TECH or MTD? 98.9% of Bio-Techne shares are held by institutional investors. Comparatively, 95.1% of Mettler-Toledo International shares are held by institutional investors. 3.9% of Bio-Techne shares are held by insiders. Comparatively, 1.9% of Mettler-Toledo International shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Do analysts recommend TECH or MTD? Bio-Techne currently has a consensus price target of $72.00, indicating a potential upside of 39.70%. Mettler-Toledo International has a consensus price target of $1,302.11, indicating a potential upside of 9.24%. Given Bio-Techne's stronger consensus rating and higher probable upside, research analysts plainly believe Bio-Techne is more favorable than Mettler-Toledo International.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bio-Techne 0 Sell rating(s) 6 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.45Mettler-Toledo International 0 Sell rating(s) 6 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.40 Is TECH or MTD more profitable? Mettler-Toledo International has a net margin of 22.29% compared to Bio-Techne's net margin of 13.22%. Bio-Techne's return on equity of 12.73% beat Mettler-Toledo International's return on equity.Company Net Margins Return on Equity Return on Assets Bio-Techne13.22% 12.73% 9.75% Mettler-Toledo International 22.29%-591.54%26.78% Does the media prefer TECH or MTD? In the previous week, Bio-Techne had 5 more articles in the media than Mettler-Toledo International. MarketBeat recorded 15 mentions for Bio-Techne and 10 mentions for Mettler-Toledo International. Mettler-Toledo International's average media sentiment score of 1.34 beat Bio-Techne's score of 0.57 indicating that Mettler-Toledo International is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Bio-Techne 4 Very Positive mention(s) 4 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Mettler-Toledo International 9 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has stronger valuation and earnings, TECH or MTD? Mettler-Toledo International has higher revenue and earnings than Bio-Techne. Mettler-Toledo International is trading at a lower price-to-earnings ratio than Bio-Techne, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBio-Techne$1.21B6.68$168.10M$0.8262.85Mettler-Toledo International$3.83B6.47$863.14M$40.1029.73 Does the MarketBeat Community believe in TECH or MTD? Bio-Techne received 33 more outperform votes than Mettler-Toledo International when rated by MarketBeat users. Likewise, 62.27% of users gave Bio-Techne an outperform vote while only 56.26% of users gave Mettler-Toledo International an outperform vote. CompanyUnderperformOutperformBio-TechneOutperform Votes40662.27% Underperform Votes24637.73% Mettler-Toledo InternationalOutperform Votes37356.26% Underperform Votes29043.74% Which has more risk and volatility, TECH or MTD? Bio-Techne has a beta of 1.38, suggesting that its stock price is 38% more volatile than the S&P 500. Comparatively, Mettler-Toledo International has a beta of 1.38, suggesting that its stock price is 38% more volatile than the S&P 500. SummaryBio-Techne beats Mettler-Toledo International on 11 of the 17 factors compared between the two stocks. Get Bio-Techne News Delivered to You Automatically Sign up to receive the latest news and ratings for TECH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TECH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TECH vs. The Competition Export to ExcelMetricBio-TechneBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$8.06B$3.09B$5.57B$8.62BDividend Yield0.64%1.58%5.28%4.18%P/E Ratio52.0633.3227.1420.06Price / Sales6.68469.84419.32157.08Price / Cash28.30168.6838.2534.64Price / Book3.923.457.064.70Net Income$168.10M-$72.35M$3.23B$247.88M7 Day Performance6.69%6.23%2.83%2.63%1 Month Performance-4.38%16.53%9.02%6.36%1 Year Performance-33.45%-16.90%31.36%14.05% Bio-Techne Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TECHBio-Techne4.8672 of 5 stars$51.54+0.3%$72.00+39.7%-33.0%$8.06B$1.21B52.063,000MTDMettler-Toledo International3.7315 of 5 stars$1,138.44-1.5%$1,302.11+14.4%-17.3%$23.66B$3.83B28.0918,000Positive NewsWATWaters4.1803 of 5 stars$343.52-1.6%$390.19+13.6%+15.4%$20.44B$2.98B32.078,200Trending NewsILMNIllumina4.8988 of 5 stars$81.09-1.4%$128.15+58.0%-22.2%$12.84B$4.34B-10.5611,500Positive NewsAnalyst ForecastOptions VolumeCRLCharles River Laboratories International4.735 of 5 stars$134.93-0.5%$171.85+27.4%-28.2%$6.63B$4.02B899.5321,400BIOBio-Rad Laboratories4.7143 of 5 stars$216.69-4.5%$327.40+51.1%-18.1%$5.90B$2.54B-3.338,200Analyst ForecastAnalyst RevisionBRKRBruker4.9605 of 5 stars$36.73+0.1%$59.10+60.9%-38.4%$5.57B$3.45B48.338,520Insider TradePACBPacific Biosciences of California2.2462 of 5 stars$0.99+2.5%$2.34+136.8%-36.3%$296.36M$152.36M-0.60730Positive NewsHBIOHarvard Bioscience3.9194 of 5 stars$0.41-13.2%$3.00+640.0%-79.1%$17.92M$91.40M-1.23490Trending NewsShort Interest ↑Gap UpHigh Trading VolumeTMOThermo Fisher Scientific4.9756 of 5 stars$396.08-1.7%$607.43+53.4%-27.9%$149.52B$42.90B23.96130,000Positive NewsAAgilent Technologies4.6303 of 5 stars$110.92-0.9%$140.15+26.4%-9.4%$31.62B$6.51B27.3917,900Positive News Related Companies and Tools Related Companies MTD Competitors WAT Competitors ILMN Competitors CRL Competitors BIO Competitors BRKR Competitors PACB Competitors HBIO Competitors TMO Competitors A Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TECH) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bio-Techne Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bio-Techne With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
